Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company announced Monday. The pharmaceutical giant is seeking to expand the use of Spravato, which is currently approved only in combination with oral antidepressants. Approval …
Summer ’24 Intern Zach Kaplan shares his reasons for joining the NORML Internship program. The post I’m Interning With NORML To Help Undo Harmful Policies appeared first on NORML.
Earlier this month, NYC authorities also dismantled a million-dollar illegal cannabis operation in Brooklyn. … New York CannabisOperation …
Ohio voters approved adult-use recreational marijuana last November, with dispensaries to be licensed by Sept. 7 … New Jersey — and probably won’t …